The synthesis and physicochemical properties of vanadium(III,IV,V) complexes with Schiff base ligands based on 3,5-dibromo-4-methoxy-salicylaldehyde and phenylacetic hydrazide ( )(EtO)] (3)} were proposed based on the elemental analysis, IR and UV-Vis spectra. Additionally, the IR and UV-Vis spectra (in solvents as well as in a solid state) have been discussed from the vanadium oxidation state point of view. The single crystal structure of 3 shows triclinic, P -1 space group, structure is stabilized by hydrogen bonds and strong π-π stacking interactions. The oxidation state of the metal centre was also confirmed by the magnetic susceptibility measurements. The stability of the complexes was measured in pH = 7.00 and in pH = 2.00 which allows to evaluate the use of these compounds as insulin mimetic compounds.
Introduction
The biological activity of vanadium compounds with organic ligands is multidirectional -they are known for exhibiting several bioactivities [1] [2] and showing potential as pharmaceutical drugs [3] . Vanadium can occur at various degrees of oxidation from -3 to +5 and the state of vanadium in a compound is highly dependent on pH [4] , most often as four-and five-valent derivatives, while compounds in the form of trivalent derivatives are unstable in the presence of oxygen under physiological conditions. Thus, in most applications and studies on biological activity vanadium is in form of V(IV) or V(V) salts. It is postulated that cation V(IV) readily oxidizes to V(V) and occurs in living organisms as an anion [5] . At the beginning simple vanadium inorganic salts were used, as vanadyl sulphate or vanadates. In 90's first vanadium(IV) complex with maltolato ligand was synthesized and soon application of more bioactive complexes with organic ligands has started. It is also worth noting that vanadium compounds exhibit large differences between them in terms of their structure and, therefore, show a difference in permeability through the cell membrane to the body. Vanadium derivatives have antidiabetic [6] [7] [8] , anticancer effects [9] [10] [11] [12] [13] and lower blood pressure [14] . What is more, it is said that they show greater activity in comparison to the commonly used anticancer drugs [15] . For many years vanadium compounds have shown also their insulin-enhancing and insulin-mimetic effects in treatment of diabetes [16] [17] . Further research on this group of transition metal complexes can lead to progress in improvement of innovative metal-based therapeutic drugs.
In this paper we described the results of the research which aim was to compare vanadium complexes with diverse structures and correlate it with their properties, which is important from the point of view of their subsequent pharmacological application. In reference to these observations, we synthesized a group of vanadium complexes at three different oxidation levels (III, IV and V) showing differences in the coordination of the metal with the ligand in order to compare their physicochemical and spectroscopic properties as potential antidiabetic drugs. The complexes were obtained from different vanadium compounds such as: [V(acac) 3 ], [VO(acac) 2 ] and VOSO 4 and ONO hydrazine Schiff base ligands derived from 3,5-dibromo-4-methoxy-salicylaldehyde with phenylacetic hydrazide, 5-chlorosalicylaldehyde with the following hydrazides: 4-hydroxybenzhydrazide and 2-hydroxybenzhydrazide. For all of the complexes the elemental analysis, IR, UV-Vis spectra, magnetic susceptibility and cyclic voltammetry, as well as EPR for one of the compounds, are presented.
Materials and Methods
[V(acac) 3 ], [VO(acac) 2 ], VOSO 4 aq, 3,5-dibromo-4-methoxy-salicylaldehyde, 5-chlorosalicylaldehyde, phenylacetic hydrazide, 4-hydroxybenzhydrazide and 2-hydroxybenzhydrazide, 1,10-phenanthroline were of analytical grade (Aldrich) and were used as supplied. Ethanol (98%) of pharmaceutical grade was from Polmos (Poland) and used as supplied. All other solvents were of analytical grade and were used as supplied. BaSO 4 was of spectroscopic grade (Japan). Microanalysis of carbon, hydrogen and nitrogen were performed using Elementar Vario MICRO Cube elemental analyzer. IR spectra were recorded on a Bruker EQUINOX 55 FT-IR spectrophotometer in KBr pellets. The electronic absorption spectra were recorded on Shimadzu UV-3600 UV-Vis-NIR spectrophotometer equipped with a CPS-240 temperature controller. Diffuse reflectance spectra were measured in BaSO 4 pellets with BaSO 4 as a reference on Shimadzu 2101PC equipped with an ISR-260 integrating sphere attachment. Complex stability measurements in DMSO/H 2 O (20 µL/3mL) mixture were performed at a pH = 7.00 and at pH = 2.00 (0.1M KCl, HCl added to adjust the pH). The spectra were measured every 340 s at 36.7 o C on Shimadzu UV-3600 UVVis-NIR spectrophotometer in 1 cm UV cuvettes. The magnetic susceptibility measurement was performed on a SHERWOOD SCIENTIFIC magnetic susceptibility balance. The EPR measurements were performed at room and liquid nitrogen temperatures with a Bruker ELEXSYS E-500 spectrometer operating at the X band (9.8 GHz) and 100 kHz magnetic field modulation equipped with super-high-sensitivity cavity ER 4122 SHQE. The EPR parameters of the vanadium complex were determined by fitting the spectra using the EPRSim32 simulation package [18] . The estimated error of the g factor was ±0.001 whereas in the case of HFS parameters the one was ±1 G.
Syntheses
The syntheses of three vanadium(III,IV,V) complexes were carried out in the one step reaction, ethanol was used as a solvent and reactions were proceeding under anaerobic conditions (Ar). The Schiff base ligands were synthesized in situ in 1 : 1 molar ratio from components (aldehydes and hydrazides) prior of vanadium source addition. 
Crystallographic data collection and structure refinement
Diffraction intensity data for single crystal of the compound 3 were collected at a room temperature on a KappaCCD (Nonius) diffractometer with graphite-monochromated Mo Kα radiation (λ = 0.71073 Å). Cell refinement and data reduction were performed using firmware [19, 20] . Positions of all of non-hydrogen atoms were determined by direct methods using SHELXL-2017/1 [21] . All non-hydrogen atoms were refined anisotropically using weighted full-matrix least-squares on F 2 . Refinement and further calculations were carried out using SHELXL 2017/1 [21] . All hydrogen atoms joined to carbon atoms were positioned with an idealized geometries and refined using a riding model with U iso (H) fixed at 1.5 U eq of C for methyl groups and 1.2 U eq of C for other groups. The hydrogen atom of -OH (O19) substituent was found in the difference-Fourier map and refined with an isotropic thermal parameter. The figures were made using DIAMOND software [22] . CCDC 1883287 contains the supplementary crystallographic data for the complex. These data can be obtained free of charge from the Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/ data_request/cif. 
Results and Discussion

Crystal structure
The complex 3 crystallizes in the triclinic space group P -1 with the asymmetric cell unit containing one molecule of [VO(L 3 ) (EtO)] complex. The crystallographic data and detailed information on the structure solution and refinement for 3 are given in Table 1 while the molecular structure with the atom labelling scheme is illustrated in Fig. 1 . The selected bond parameters are summarized in Table 2 . Vanadium is in distorted square pyramidal geometry, with (L   3   ) 2-and EtO -in pyramid plane. Ligand Figure 1 . The asymmetric part of the unit cell of the complex 3 with adopted atomic numbering scheme. All non-hydrogen atoms are represented at 30%
probability thermal ellipsoids
The molecular packing is shown in Fig. 2 . The structure is stabilized by a net of hydrogen bonds, shown in Fig. 3 and strong π-π interactions shown in Fig. 4 . The numerical data are presented in Table 3 and 4. The D-A distances indicate that hydrogen bonds are relatively long, the DHA angle rather far from 180 o indicate that hydrogen bonds are very weak. The structure is stabilized also by π-π stacking interactions listed in Table 4 and shown in Fig. 4 . The stacking interaction are in between aromatic rings of ligand L 3 . All these interactions form a three-dimensional net that stabilize the structure of 3. Symmetry transformations used to generate equivalent atoms: #1 -x+1,-y+1,-z #2 x-1,y-1,z 
Bond lengths
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) C(8)-H(8Cg1····Cg2 [1-X,1-Y,-Z] 3.9518(3) Cg2····Cg1 [1-X,1-Y,-Z] 3.9518(3) Cg1: C(1)-C(2)-C(3)-C(4)-C(5)-C(6) Cg2: C(13)-C(14)-C(15)-C(16)-C(17)-C(18)
IR spectra
The infrared spectra for 1-3 were recorded in a 400 -4000 cm 
UV-Vis spectra
The UV-VIS spectra in 200-800 nm range are presented in , present in the complex unit. The reflectance spectra of 1 and 3 are presented in Fig. 9 . The lack of the bands in the d-d region (above 700 nm) underlines the V(III) and V(V) oxidation states in 1 and 3 respectively.
The most important was to study the stability of the complexes in solutions as well as dependence of this stability at different pH. As for biological studies the solutions of complexes have to be prepared, which then were injected to cell cultures, the stability of solutions was crucial. Also the solubility in water was very important. We have found, that all complexes are almost insoluble in water, thus we had to prepare water-organic solvent mixtures. The highest solubility of all complexes was found in DMSO as solvent, thus for this solvent water-DMSO mixtures of lowest organic solvent content could be prepared. We have also found, that solutions in DMSO are very stable in time and mixtures of 20 µl of DMSO complex solution with 3 ml of water could be prepared without complex precipitation. We have studied the stability of such mixtures versus time at pH neutral (7.0) and at pH 2.0, this last as representing the medium pH found in human stomach. The results of this investigations are presented in Figs. 10-12 . In general most stable are the solutions at pH = 7.0, while at pH = 2 we observed the strong diminishing of the band in 400 nm region indicating complex decomposition with releasing the ONO ligands L. 
EPR spectrum
The EPR spectrum of complex 1 is presented in Fig. 13 . Due to measured magnetic moment of 2.55 µ B (calculated for V(I-II) 2.83 µ B , for V(IV) 1.73 µ B ), it must be stressed, that 1 contains V(III), not visible in the EPR X-band, and only very small amounts of V(IV). The presence of this signal ( 
Conclusions
Three new complexes of V(III), V(IV) and V(V) with tridentate ONO Schiff base ligands were synthesized and characterized. The X-ray single crystal structure of complex 3 indicates rare pure square pyramidal geometry of vanadium central atom. The EPR measurements show, that V(III) is contaminated with a small amount of V(IV) oxido complex, while most of the complex is of nonoxido type. The stability of the solutions indicate, that they can be used for cell culture media investigations, but in in vivo studies injections are recommended as complexes are relatively unstable at pH typical for digestion system. 
